BANK VONTOBEL/CALL/MERCK & CO./140/0.1/20.12.24 Share Price

Warrant

DE000VD3SE22

Real-time Boerse Frankfurt Warrants 02:09:42 13/06/2024 pm IST
0.38 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./140/0.1/20.12.24
Current month+35.71%
1 month-13.64%
Date Price Change
13/24/13 0.38 0.00%
12/24/12 0.38 -9.52%
11/24/11 0.42 +2.44%
10/24/10 0.41 +5.13%
07/24/07 0.39 +8.33%

Real-time Boerse Frankfurt Warrants

Last update June 13, 2024 at 02:09 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SE2
ISINDE000VD3SE22
Date issued 09/04/2024
Strike 140 $
Maturity 20/12/2024 (191 Days)
Parity 10 : 1
Emission price 0.41
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.57
Lowest since issue 0.28
Spread 0.03
Spread %7.50%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2 USD
Average target price
142.7 USD
Spread / Average Target
+9.59%
Consensus